“…The amyloid-β peptide 1 – 42 formed during proteolytic processing of the amyloid precursor protein (APP) is considered as a key player in the development or progression of Alzheimer’s disease (AD) and other pathologies associated with the formation of protein aggregates in the central nervous system ([ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ] and many others). Although much attention is paid to formation of extracellular amyloid plaques and protein aggregates as well as to corresponding mechanisms of their toxicity, good evidence exists that intracellular amyloid-β can accumulate intraneuronally and contribute to disease progression [ 4 , 9 , 10 , 11 , 12 , 13 , 14 , 15 ].…”